Procter & Gamble price target lowered to $180 from $191 at Morgan Stanley

Morgan Stanley analyst Dara Mohsenian lowered the firm’s price target on Procter & Gamble to $180 from $191 and keeps an Overweight rating on the shares. Fiscal Q3 “quality was soft,” with muted underlying organic sale growth further pressured by U.S. retailer inventory cuts and lower fiscal year EPS guidance on topline softness and incremental tariffs, the analyst tells investors. Post Q3 results, the firm lowered its FY26 EPS estimate by 3%, but remains Overweight with organic sale growth expected to rebound to 2%-3% going forward and its prior expectation for negative EPS revisions “now played out.”